DK3662926T3 - Biologisk aktive insulinderivater - Google Patents

Biologisk aktive insulinderivater Download PDF

Info

Publication number
DK3662926T3
DK3662926T3 DK19208086.9T DK19208086T DK3662926T3 DK 3662926 T3 DK3662926 T3 DK 3662926T3 DK 19208086 T DK19208086 T DK 19208086T DK 3662926 T3 DK3662926 T3 DK 3662926T3
Authority
DK
Denmark
Prior art keywords
biologically active
insulin derivatives
active insulin
derivatives
biologically
Prior art date
Application number
DK19208086.9T
Other languages
English (en)
Inventor
Kleomenis Barlos
Dimitrios Gatos
Kostas Barlos
Michail Ziovas
Original Assignee
Chemical & Biopharmaceutical Laboratories Of Patras S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemical & Biopharmaceutical Laboratories Of Patras S A filed Critical Chemical & Biopharmaceutical Laboratories Of Patras S A
Application granted granted Critical
Publication of DK3662926T3 publication Critical patent/DK3662926T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK19208086.9T 2013-12-05 2014-12-04 Biologisk aktive insulinderivater DK3662926T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1321489.5A GB201321489D0 (en) 2013-12-05 2013-12-05 Biologically active insulin derivatives
EP14833536.7A EP3076990B1 (en) 2013-12-05 2014-12-04 Biologically active insulin derivatives

Publications (1)

Publication Number Publication Date
DK3662926T3 true DK3662926T3 (da) 2023-12-11

Family

ID=50000217

Family Applications (2)

Application Number Title Priority Date Filing Date
DK14833536.7T DK3076990T3 (da) 2013-12-05 2014-12-04 Biologisk aktive insulinderivater
DK19208086.9T DK3662926T3 (da) 2013-12-05 2014-12-04 Biologisk aktive insulinderivater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK14833536.7T DK3076990T3 (da) 2013-12-05 2014-12-04 Biologisk aktive insulinderivater

Country Status (12)

Country Link
US (1) US10195287B2 (da)
EP (2) EP3076990B1 (da)
JP (1) JP6798883B2 (da)
CN (3) CN118909080A (da)
AU (2) AU2014358699A1 (da)
DK (2) DK3076990T3 (da)
ES (2) ES2965765T3 (da)
GB (1) GB201321489D0 (da)
HK (1) HK1223834A1 (da)
IL (1) IL245983B (da)
PL (1) PL3662926T3 (da)
WO (1) WO2015083114A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201321489D0 (en) 2013-12-05 2014-01-22 Chemical & Biopharmaceutical Lab Of Patras S A Biologically active insulin derivatives
BR112019004314A2 (pt) * 2016-09-06 2019-05-28 Chemical & Biopharmaceutical Laboratories Of Patras S A derivados pró-insulina

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3847893A (en) * 1972-03-01 1974-11-12 Bayer Ag Process for the preparation of insulin derivatives cross-linked by a dicarboxylic acid group at the amino a-1 glycine and amino b-29 lysine
DK58285D0 (da) 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
DK10191D0 (da) 1991-01-22 1991-01-22 Novo Nordisk As Hidtil ukendte peptider
WO1995016708A1 (en) 1993-12-17 1995-06-22 Novo Nordisk A/S Proinsulin-like compounds
AU5724996A (en) 1995-05-05 1996-11-21 Eli Lilly And Company Single chain insulin with high bioactivity
GB9812675D0 (en) 1998-06-11 1998-08-12 Univ Edinburgh Peptides
ATE270306T1 (de) 2000-10-02 2004-07-15 Univ Yonsei Seoul Einkettige insulinanaloge
JP5697831B2 (ja) * 2003-12-03 2015-04-08 ノヴォ ノルディスク アー/エス 単鎖インシュリン
WO2006079641A2 (en) * 2005-01-27 2006-08-03 Novo Nordisk A/S Insulin derivatives conjugated with structurally well defined branched polymers
JP2008533100A (ja) 2005-03-18 2008-08-21 ノボ ノルディスク アクティーゼルスカブ Peg化された単鎖インスリン
EP1991575A1 (en) 2006-02-21 2008-11-19 Novo Nordisk A/S Single-chain insulin analogues and pharmaceutical formulations thereof
JP2009530243A (ja) 2006-03-13 2009-08-27 ノボ・ノルデイスク・エー/エス アシル化単鎖インスリン
WO2008043033A2 (en) 2006-10-04 2008-04-10 Case Western Reserve University Fibrillation-resistant insulin and insulin analogues
ES2548304T3 (es) * 2007-08-15 2015-10-15 Novo Nordisk A/S Análogos de la insulina que contienen una fracción acilo y alquilenglicol
US8618049B2 (en) * 2009-09-08 2013-12-31 Stephen B. H. Kent Ester insulin
EP2582719B1 (en) * 2010-06-16 2016-08-10 Indiana University Research and Technology Corporation Single chain insulin agonists exhibiting high activity at the insulin receptor
CN104114183A (zh) * 2011-12-20 2014-10-22 印第安纳大学研究及科技有限公司 用于治疗糖尿病的基于ctp的胰岛素类似物
GB201321489D0 (en) 2013-12-05 2014-01-22 Chemical & Biopharmaceutical Lab Of Patras S A Biologically active insulin derivatives

Also Published As

Publication number Publication date
ES2773960T3 (es) 2020-07-15
CN105793283A (zh) 2016-07-20
PL3662926T3 (pl) 2024-05-13
JP6798883B2 (ja) 2020-12-09
HK1223834A1 (zh) 2017-08-11
IL245983B (en) 2020-03-31
AU2014358699A1 (en) 2016-06-09
US10195287B2 (en) 2019-02-05
EP3076990B1 (en) 2020-01-22
AU2017248496A1 (en) 2017-11-09
ES2965765T3 (es) 2024-04-16
AU2017248496B2 (en) 2019-08-29
EP3662926A1 (en) 2020-06-10
DK3076990T3 (da) 2020-03-16
JP2017501991A (ja) 2017-01-19
CN118909080A (zh) 2024-11-08
IL245983A0 (en) 2016-07-31
EP3076990A2 (en) 2016-10-12
WO2015083114A3 (en) 2015-11-26
GB201321489D0 (en) 2014-01-22
EP3662926B1 (en) 2023-10-25
WO2015083114A2 (en) 2015-06-11
CN118909079A (zh) 2024-11-08
CA2931439A1 (en) 2015-06-11
US20160375146A1 (en) 2016-12-29

Similar Documents

Publication Publication Date Title
DK2968880T3 (da) Lægemiddelafgivelsesindretninger med lægemiddelpermeabel komponent
EP2968894A4 (en) MEDICAL CONNECTOR
DK4056212T3 (da) Autoinjektor
PL3623002T3 (pl) Cewnik
BR112016009485A2 (pt) Inalador de medicamento
EP3750590C0 (en) THRESHOLD RELEASE ADMINISTRATION CAPSULE
EP2968867C0 (en) CATHETER ASSEMBLY
DK2900645T3 (da) Herbicidt aktive 3-phenylisoxazolinderivater
EP2982401A4 (en) Drug injection syringe
EP2967969C0 (en) IMPLANT
DK3590566T3 (da) Kropsbåret injektor
DK3038674T3 (da) Medikamentafgivelsesindretning
DK2970389T3 (da) Farmaceutiske forbindelser
HUE060756T2 (hu) Fungicid hatású készítmények
BR112016011147A2 (pt) autoinjetor
IL240782B (en) Stent
BR112016014772A2 (pt) derivados dihidro-hidantoína com atividade herbicida
PL2945641T3 (pl) Cykloalkinowe pochodne sacharydów
DK2967936T3 (da) Skrå stent
DK3089778T3 (da) Ballonkateter
PT2980085T (pt) Compostos farmaceuticamente activos
DK2983747T3 (da) Lægemiddelindgivelsesindretning
BR112015028948A2 (pt) gerenciamento de entrega de medicamento
EP3000444A4 (en) STENT
IL245983A0 (en) Biologically active insulin derivatives